Innovative Industrial Properties, Inc. declared its Q4 2025 dividend on December 15, 2025. The board approved a regular quarterly dividend of $0.5625 per share on its 9.00% Series A Cumulative Redeemable Preferred Stock, payable on January 15, 2026 to shareholders of record as of December 31, 2025. This distribution represents a continuation of IIPR’s disciplined dividend policy and underscores its commitment to returning capital to investors from its growing portfolio of specialized industrial and life science properties.

As of year-end 2025, IIPR’s real estate portfolio comprised 127 properties across 20 states, totaling over 18.2 million square feet of specialized industrial space. During the quarter, the company closed three new sale-leaseback transactions valued at $82 million, reflecting an average lease term of 15 years and initial cash yields in the range of 9.2% to 9.8%. Portfolio occupancy remained steady at 98.5%, with weighted-average remaining lease term (WALT) of 11.8 years, providing predictable cash flows and visibility into long-term revenue.

IIPR ended 2025 with consolidated debt of $1.24 billion and net debt/adjusted EBITDA of 1.3x, among the lowest leverage ratios in the REIT sector. The company maintained $195 million of liquidity available under its unsecured revolving credit facility and held $72 million in unrestricted cash. This conservative capital structure, combined with no significant debt maturities until mid-2028, positions IIPR to fund accretive acquisitions and sustain its dividend during potential market volatility.

Innovative Industrial Properties currently trades at approximately 8.0x adjusted funds from operations (FFO) for 2026 estimates and offers a forward dividend yield near 15%. Compared with traditional industrial REIT peers, IIPR’s valuation discount reflects both cannabis-related asset specialization and regulatory considerations. However, with continued balance sheet enhancement, stable cash yields from long-term leases and high barriers to entry for new greenhouse-style facilities, IIPR presents an attractive risk-adjusted return profile for income-focused investors seeking exposure to the medical cannabis real estate niche.